Alexander Jambor

Mr. Alexander Jambor

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2019 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
DJDarian S. James
Darian S. James
AJAlexander Jambor
Alexander Jambor
HCHsin-Yu Chang
Hsin-Yu Chang
ZAZachary Alden
Zachary Alden
KTKarissa B. Tilbury
Karissa B. Tilbury
PCPaul Campagnola
Paul Campagnola
Idiopathic pulmonary fibrosis (IPF) is a form of interstitial lung disease that is a progressive disorder characterized by unrelenting scarring and stiffening of the lungs that leads to ∼34,000 deaths each year. The interstitial fibrosis is characterized by spatial and temporal heterogeneity; for example, areas of dense collagen accumulation (old scar) are juxtaposed with fibroblastic foci (new scar formation).1 As scarring increases, efficient lung function decreases, compromising the uptake of oxygen by blood, resulting in shortness of breath, limited exercise capability, and daily cough. The median survival for patients diagnosed with IPF is typically 3 to 5 years post-diagnosis.

4 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
KGKristal Gant
Kristal Gant
AJAlexander Jambor
Alexander Jambor
ZLZihui Li
Zihui Li
EREric C. Rentchler
Eric C. Rentchler
PWPaul Weisman
Paul Weisman
PCPaul Campagnola
Paul Campagnola
Background: The collagen architecture in high grade serous ovarian cancer (HGSOC) is highly remodeled compared to the normal ovary and the fallopian tubes (FT). We previously used Second Harmonic Generation (SHG) microscopy and machine learning to classify the changes in collagen fiber morphology occurring in serous tubal intraepithelial carcinoma (STIC) lesions that are concurrent with HGSOC. We now extend these studies to examine collagen remodeling in pure p53 signatures, STICs and normal regions in tissues that have no concurrent HGSOC. This is an important distinction as high-grade disease can result in distant collagen changes through a field effect mechanism. Methods: We trained a linear discriminant model based on SHG texture and image features as a classifier to discriminate the tissue groups. We additionally performed mass spectrometry analysis of normal and HGSOC tissues to associate the differential expression of collagen isoforms with collagen fiber morphology alterations. Results: We quantified the differences in the collagen architecture between normal tissue and the precursors with good classification accuracy. Through proteomic analysis, we identified the downregulation of single α-chains including those for Col I and III, where these results are consistent with our previous SHG-based supramolecular analyses. Conclusion: This work provides new insights into ECM remodeling in early ovarian cancer and suggests the combined use of SHG microscopy and mass spectrometry as a new diagnostic/prognostic approach.

4 February 2026 in Nature
Verified
Journal Article
Open access
PDF file
HCH. Kay Chung
H. Kay Chung
CLCong Liu
Cong Liu
ABAnamika Battu
Anamika Battu
AJAlexander Jambor
Alexander Jambor
BPBrandon M. Pratt
Brandon M. Pratt
WWWei Wang
Wei Wang
CD8 + T cells differentiate into diverse states that shape immune outcomes in cancer and chronic infection 1–4 . To define systematically the transcription factors (TFs) driving these states, we built a comprehensive atlas integrating transcriptional and epigenetic data across nine CD8 + T cell states and inferred TF activity profiles. Our analysis catalogued TF activity fingerprints, uncovering regulatory mechanisms governing selective cell state differentiation. Leveraging this platform, we focused on two transcriptionally similar but functionally opposing states that are critical in tumour and viral contexts: terminally exhausted T (TEX term ) cells, which are dysfunctional 5–8 , and tissue-resident memory T (T RM ) cells, which are protective 9–13 . Global TF community analysis revealed distinct biological pathways and TF-driven networks underlying protective versus dysfunctional states. Through in vivo CRISPR screening integrated with single-cell RNA sequencing (in vivo Perturb-seq) we delineated several TFs that selectively govern TEX term cell differentiation. We also identified HIC1 and GFI1 as shared regulators of TEX term and T RM cell differentiation and KLF6 as a unique regulator of T RM cells. We discovered new TEX term -selective TFs, including ZSCAN20 and JDP2, with no previous known function in T cells. Targeted deletion of these TFs enhanced tumour control and synergized with immune checkpoint blockade but did not interfere with T RM cell formation. Consistently, their depletion in human T cells reduces the expression of inhibitory receptors and improves effector function. By decoupling exhaustion T EX -selective from protective T RM cell programmes, our platform enables more precise engineering of T cell states, accelerating the rational design of more effective cellular immunotherapies.

25 August 2021 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
AJAlexander Jambor
Alexander Jambor
ESE.M. Shelton
E.M. Shelton
RKR. Kijowski
R. Kijowski
CHC.R. Henak
C.R. Henak
PCPaul Campagnola
Paul Campagnola

18 March 2026 in Nature
Verified
Journal Article
Open access
HCH. Kay Chung
H. Kay Chung
CLCong Liu
Cong Liu
ABAnamika Battu
Anamika Battu
AJAlexander Jambor
Alexander Jambor
BPBrandon M. Pratt
Brandon M. Pratt
WWWei Wang
Wei Wang

11 June 2026 in Research Square
Verified
Preprint
Open access
PDF file
JMJ. Justin Milner
J. Justin Milner
BPBrandon Pratt
Brandon Pratt
GMGenevieve Mullins
Genevieve Mullins
NBNolan Brown
Nolan Brown
LRLara van Rooyen
Lara van Rooyen
HCH. Kay Chung
H. Kay Chung
CD8⁺ T cells mediate host defense and tumor immunity through specialized differentiation states, yet the regulatory programs that guide these states may also limit their functional potential. Loss-of-function studies have defined many regulators required for T cell differentiation, but they do not readily reveal regulatory activities that emerge only when transcription factors are ectopically expressed outside their native lineage, dosage, or temporal context. Here, we developed single-cell gain-of-functon(GOF) sequencing (scGOF-seq), a multiplexed platform for in vivo mapping of transcription factor overexpression in antigen-specific CD8⁺ T cells across immunocompetent models of infection and cancer. By enforcing expression of canonical T cell regulators, lineage-silenced developmental factors, and temporally restricted transcription factors, scGOF-seq uncovered unexpected in vivo activities. Developmental regulators normally silenced in T cells, including NANOG, SOX2, OCT4 and GATA2, reshaped T cell differentiation in context-dependent ways, with NANOG promoting stemness-associated phenotypes and accumulation during chronic infection. In parallel, sustained cMyc expression outside its native temporal window generated a stem-like, effector-featured state with enhanced metabolic fitness, reduced terminal exhaustion, and profound antigen-dependent expansion exceeding 5,000-fold. Importantly, cMyc GOF maintained cell-cycle checkpoint signatures and demonstrated a strong dependence on antigen presence for proliferation across the tested conditions. scGOF-seq further identified cooperating transcription factor modules that complemented cMyc-driven programs and improved T cell responses in solid tumors. These findings establish systematic GOF perturbation as a framework for uncovering latent and temporally constrained regulatory activities in CD8⁺ T cells and guiding immune-state engineering.